José-Luis Martínez

42PUBLICATIONS
34CO-AUTHORS
Medical infection agents (incl. prions)Biological controlMedical mycologyMedical molecular engineering of nucleic acids and proteinsCarbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Apr 09, 2025
Ceftazidime-avibactam use selects multidrug-resistance and prevents designing collateral sensitivity-based therapies against Pseudomonas aeruginosa.

Sara Hernando-Amado, María A Gomis-Font, José R Valverde

|Jul 17, 2024
Preserving the efficacy of antibiotics to tackle antibiotic resistance.

Pablo Laborda, Teresa Gil-Gil, José Luis Martínez

|May 31, 2024
Role of bacterial multidrug efflux pumps during infection.

Pablo Laborda, Søren Molin, Helle Krogh Johansen

|Apr 26, 2024
Evolution of Resistance against Ciprofloxacin, Tobramycin, and Trimethoprim/Sulfamethoxazole in the Environmental Opportunistic Pathogen Stenotrophomonas maltophilia.

Luz Edith Ochoa-Sánchez, José Luis Martínez, Teresa Gil-Gil

|Mar 23, 2024
Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance.

Pablo Laborda, Signe Lolle, Sara Hernando-Amado

|Dec 23, 2023
The Inactivation of the Putative Two-Component System Sensor PA14_27940 Increases the Susceptibility to Several Antibiotics and Reduces the Motility of Pseudomonas aeruginosa.

Roberta Genova, Teresa Gil-Gil, Trinidad Cuesta

Pageof 7

Frequent Collaborators

13 joint publications

Sara Hernando-Amado

9 joint publications

Pablo Laborda

8 joint publications

Teresa Gil-Gil

5 joint publications

Fernando Sanz-García